American International Group, Inc. Werewolf Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.43 - $5.98 $44,970 - $78,403	-13,111 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.71 - $12.22 $3,424 - $11,279	-923 Reduced 6.58%	13,111 $58,000
Q4 2021 Feb 11, 2022	BUY	$11.48 - $17.65 $113,548 - $174,576	9,891 Added 238.74%	14,034 $167,000
Q3 2021 Nov 12, 2021	SELL	$13.89 - $20.31 $1,361 - $1,990	-98 Reduced 2.31%	4,143 $71,000
Q2 2021 Aug 13, 2021	BUY	$11.6 - $17.44 $49,195 - $73,963	4,241 New	4,241 $74,000

32.2M

53.8K

1.3K

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $62.6M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.